Kabira Technologies

Magnolia Medical Technologies, based in San Mateo, CA, is committed to enhancing diagnostic accuracy in the healthcare sector, particularly in the realm of sepsis testing. Their flagship product, the Steripath Initial Specimen Diversion Device, is designed to reduce blood culture contamination, ultimately supporting improved clinical decision-making and patient outcomes.

Fueled by a mission to eliminate misdiagnosis of sepsis, Magnolia Medical emphasizes innovation and evidence-backed solutions that address critical issues such as antibiotic overuse and healthcare costs associated with false-positive results. Through their advancements, they aim to create a healthcare environment free of in-vitro diagnostic errors.

Generated from the website